# GNA Biosolutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gna-biosolutions

- Industry: Medical Devices & Equipment
- Headquarters: Germany
- Website: www.gna-bio.com
- Total disclosed funding: $20M
- Latest round: Series C (Aug 1, 2019)
- Investors on record: 9

## About

Founded in 2010 and based in Germany, GNA Biosolutions GmbH is a company that develops pulse controlled amplification (PCA) assays and instruments for detection of biomolecules. The PCA technology the company develops makes the molecular testing process simpler than the conventional molecular testing.

## Funding rounds

- Series C, Aug 1, 2019, $14M — SHS Gesellschaft fur Beteiligungsmanagement, Robert Bosch Venture Capital, b2venture, Bayern Kapital, Mey Capital Matrix, Unternehmertum Venture Capital, GreyBird Ventures, Occident Group
- Series B, Jul 1, 2015, $6.6M — KfW Banking Group, SHS Gesellschaft fur Beteiligungsmanagement, Robert Bosch Venture Capital, b2venture, Unternehmertum Venture Capital

## Investors

- KfW Banking Group — Series B
- SHS Gesellschaft fur Beteiligungsmanagement (https://capitalatlas.ai/funds/shs-gesellschaft-fur-beteiligungsmanagement) — Series B, Series C
- Robert Bosch Venture Capital (https://capitalatlas.ai/funds/robert-bosch-venture-capital) — Series B, Series C
- b2venture (https://capitalatlas.ai/funds/b2venture) — Series B, Series C
- Unternehmertum Venture Capital (https://capitalatlas.ai/funds/unternehmertum-venture-capital) — Series B, Series C
- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Series C
- Mey Capital Matrix (https://capitalatlas.ai/funds/mey-capital-matrix) — Series C
- GreyBird Ventures (https://capitalatlas.ai/funds/greybird-ventures) — Series C
- Occident Group — Series C